Quantitative CT Extent of Lung Damage in COVID-19 Pneumonia Is an Independent Risk Factor for Inpatient Mortality in a Population of Cancer Patients: A Prospective Study
Toulsie Ramtohul(Université Paris Sciences et Lettres), Vincent Servois(Université Paris Sciences et Lettres), A. Tardivon(Université Paris Sciences et Lettres), Aurélien Noret(Institut Curie), Paul Cottu(Université Paris Sciences et Lettres), P. Chérel(Institut Curie), L. Chiche(Université de Bordeaux), Perrine Vuagnat(Université de Versailles Saint-Quentin-en-Yvelines), Luc Cabel(Université de Versailles Saint-Quentin-en-Yvelines), Pauline Moreau(Institut Curie), Xavier Paolettí(Inserm), François‐Clément Bidard(Inserm)
Cited by 15
Related Papers
Elacestrant (oral selective estrogen receptor degrader) Versus Standard Endocrine Therapy for Estrogen Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Advanced Breast Cancer: Results From the Randomized Phase III EMERALD Trial
|Journal of Clinical Oncology|2022|676
Circulating Tumor Cells in Breast Cancer Patients Treated by Neoadjuvant Chemotherapy: A Meta-analysis
|JNCI Journal of the National Cancer Institute|2018|282
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper
|Critical Reviews in Oncology/Hematology|2018|268
Recommendations for Bowel Obstruction With Peritoneal Carcinomatosis
|Journal of Pain and Symptom Management|2014|139